Advertisement

Research Summaries

Research Summary
Research Summary
03/30/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers compared the health outcomes of adult patients with moderate ulcerative colitis and early advanced therapy initiation with those who delayed their advanced treatment initiation.
03/30/2024
Research Summary
Research Summary
03/28/2024

Jessica Ganga

Jessica Ganga
Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...
03/28/2024
Research Summary
Research Summary
03/27/2024

Anthony Calabro, MA

Anthony Calabro, MA
Nearly 108,000 Americans died of drug overdoses in 2022, surpassing the previous year’s record total, according to a CDC report. Although the official number of deaths caused by overdoses—107,941—breaks the...
03/27/2024
Research Summary
Research Summary
03/26/2024

Jessica Ganga

Jessica Ganga
The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...
03/26/2024
research summary
research summary
03/26/2024

Leigh Precopio

Leigh Precopio
Researchers examined if venetoclax—a therapy commonly used in the treatment of acute myelogenous leukemia and chronic lymphocytic leukemia—was associated with an increased risk of opportunistic infections,...
03/26/2024
Research summary
Research summary
03/22/2024

Jessica Ganga

Jessica Ganga
Researchers sought to determine whether patients with type 2 diabetes and obesity experience continued type 2 diabetes remission.
03/22/2024
FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.
03/21/2024
FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
On March 8, the FDA approved the injectable weight loss medication, semaglutide, for reducing the risk of cardiovascular events such as heart attack, stroke, and cardiovascular death in adults with heart...
03/21/2024
Research Summary
Research Summary
03/20/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
03/20/2024
FDA Alert
FDA Alert
03/19/2024

Jessica Ganga

Jessica Ganga
The FDA approved two gene therapies, the first of their kind, to treat patients aged 12 years and older with sickle cell disease.
03/19/2024